To include your compound in the COVID-19 Resource Center, submit it here.

Hepatic

INDICATION: Non-alcoholic steatohepatitis (NASH)

Patient sample, mouse and monkey studies suggest promoting TNFAIP3 expression could help treat NASH. In patient liver samples

Read the full 210 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE